Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unveiling the role of TAGLN2 in glioblastoma: From proneural-mesenchymal transition to Temozolomide resistance

9 Jul 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Glioma Diagnosis and Treatment
Share to MicroRNA in disease regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38992489
DOI: 10.1016/j.canlet.2024.217107

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unveiling the role of TAGLN2 in glioblastoma: From proneural-mesenchymal transition to Temozolomide resistancePMID 38992489Read ↗

Molecular drivers of epithelial-mesenchymal transition (EMT) in glioblastoma and impact on therapy resistanceSemantic proximity Read ↗

RPL22L1, a Novel Candidate Oncogene Promotes Temozolomide Resistance by Activating STAT3 in GlioblastomaSemantic proximity Read ↗

Glioblastoma: histone mutations take the MYCN.Semantic proximity Read ↗

Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme.Semantic proximity Read ↗

TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.Semantic proximity Read ↗

Molecular targeting of glioblastoma: Drug discovery and therapiesSemantic proximity Read ↗

IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastomaSemantic proximity Read ↗

Loss of ELAVL2 is associated with aggressive mesenchymal transition in glioblastomaSemantic proximity Read ↗

Loss of CD99L2 contributed to temozolomide resistance and glioblastoma tumorigenesis based on Genome-scale CRISPR/Cas9 screeningSemantic proximity Read ↗

GALNT2 sustains glioma stem cells by promoting CD44 expressionSemantic proximity Read ↗

TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathwaySemantic proximity Read ↗

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signalingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.